Symptomatic CNS metastases — ICI doublet (nivo+ipi) intracranially active; BRAFi+MEKi for...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-MELANOMA-TRANSFORMATION-PROGRESSION |
|---|---|
| Type | Red flag |
| Status | pending_clinical_signoff |
| Diseases | DIS-MELANOMA |
| Sources | SRC-ESMO-MELANOMA-2024 SRC-NCCN-MELANOMA-2025 |
Red Flag Origin
| Definition | Symptomatic CNS metastases — ICI doublet (nivo+ipi) intracranially active; BRAFi+MEKi for visceral crisis. |
|---|---|
| Clinical direction | intensify |
| Category | transformation-progression |
Trigger Logic
{
"any_of": [
{
"finding": "symptomatic_cns_metastases",
"value": true
}
],
"type": "composite_clinical"
}
Notes
CheckMate-204: nivo+ipi ICR ~46% in active brain mets.
Used By
Algorithms
ALGO-MELANOMA-METASTATIC-1L- ALGO-MELANOMA-METASTATIC-1L
Indications
IND-MELANOMA-3L-POST-LIFILEUCEL- IND-MELANOMA-3L-POST-LIFILEUCELIND-MELANOMA-NIVO-MAINT- IND-MELANOMA-NIVO-MAINT